Jun 17, 2019
IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent's Paragon Gene Therapy for Orphan Inherited Retinal Diseases
May 07, 2019
Paragon Bioservices Strengthens its Commitment to World Class GMP Viral Therapy Manufacturing with the Appointment of Two Key Leadership Positions and Advanced Commitment to Quality
Apr 15, 2019
Paragon announces its second GMP manufacturing facility and the expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics
Apr 15, 2019
Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion
Apr 11, 2019
Paragon Bioservices Celebrates Grand Opening of its World-Class Gene Therapy Biomanufacturing Facility
Mar 21, 2019
Paragon Bioservices Appoints New CTSO, Bolsters Leadership Ranks to Support Late-Stage Clinical and Commercial Biopharmaceutical Manufacturing
Nov 19, 2018
Paragon Bioservices Named to Deloitte's Technology Fast 500(TM)
Aug 08, 2018
Paragon Bioservices Announces Two Key Leadership Promotions
Jun 06, 2018
Paragon Bioservices Fills Key Leadership Position with New CFO Hire
May 18, 2018
Paragon Bioservices Recognized as Life Science Company of the Year by Maryland Tech Council
Jan 25, 2018
Paragon Bioservices Bolsters Leadership Ranks with Executive Appointments, New Vice President Hires
Jan 23, 2018
Paragon Bioservices Announces New Commercial Manufacturing Facility Expansion
Dec 18, 2017
Paragon Bioservices Named to Baltimore Business Journal's "Fast 50" 2017
Jul 20, 2017
Paragon Appoints Deborah Wild as VP Quality and Regulatory Affairs